Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Flexion Therapeutics Inc | Chief Financial Officer | Common Stock | 221K | $1.88M | $8.50 | May 10, 2021 | Direct |
Seres Therapeutics, Inc. | Chief Financial Officer | Common Stock | 182K | $197K | $1.08 | Feb 16, 2024 | Direct |
Seres Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 31.9K | $43K | $1.35 | Feb 15, 2024 | Direct |
Seres Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 288K | Feb 14, 2024 | Direct | ||
KINETA, INC./DE | Director | Stock Option (Right to Buy) | 12.5K | Sep 4, 2024 | Direct | ||
F-star Therapeutics, Inc. | Director | Common Stock | 0 | $7.12 | Mar 8, 2023 | Direct | |
F-star Therapeutics, Inc. | Director | Warrant (right to buy) | 0 | Nov 20, 2020 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KA | KINETA, INC./DE | Sep 4, 2024 | 1 | $0 | 4 | Sep 5, 2024 | Director |
MCRB | Seres Therapeutics, Inc. | Feb 14, 2024 | 6 | -$4.25K | 4 | Feb 16, 2024 | Chief Financial Officer |
MCRB | Seres Therapeutics, Inc. | Oct 27, 2023 | 4 | -$5.49K | 4 | Oct 31, 2023 | Chief Financial Officer |
MCRB | Seres Therapeutics, Inc. | Apr 27, 2023 | 1 | $0 | 4 | May 1, 2023 | Chief Financial Officer |
KA | KINETA, INC./DE | Apr 12, 2023 | 2 | $0 | 4 | Apr 14, 2023 | Director |
MCRB | Seres Therapeutics, Inc. | Feb 3, 2023 | 2 | $0 | 4 | Feb 7, 2023 | Chief Financial Officer |
MCRB | Seres Therapeutics, Inc. | Jul 5, 2022 | 1 | $200K | 4 | Jul 6, 2022 | Chief Financial Officer |
FSTX | F-star Therapeutics, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 15, 2022 | 3 | $0 | 4 | Oct 31, 2022 | Chief Financial Officer |
MCRB | Seres Therapeutics, Inc. | Feb 4, 2022 | 1 | $0 | 4 | Feb 8, 2022 | Executive Vice President, Chief Financial Officer and Head of Business Development |
FSTX | F-star Therapeutics, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |
KA | YUMANITY THERAPEUTICS, INC. | Jun 2, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 1, 2021 | 2 | $0 | 4 | Jun 1, 2021 | Chief Financial Officer |
MCRB | Seres Therapeutics, Inc. | Jun 1, 2021 | 0 | $0 | 3 | Jun 1, 2021 | Chief Financial Officer |
FLXN | Flexion Therapeutics Inc | May 10, 2021 | 1 | -$16.1K | 4 | May 12, 2021 | Chief Financial Officer |
FSTX | F-star Therapeutics, Inc. | Nov 20, 2020 | 10 | -$59.7K | 4 | Mar 9, 2023 | Director |